These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
239 related items for PubMed ID: 26363852
1. Effects of footshocks on anxiety-like behavior and mRNA levels of precursor peptides for corticotropin releasing factor and opioids in the forebrain of the rat. Wang H, Li S, Kirouac GJ. Neuropeptides; 2015 Dec; 54():1-7. PubMed ID: 26363852 [Abstract] [Full Text] [Related]
2. Coexpression of prodynorphin and corticotrophin-releasing hormone in the rat central amygdala: evidence of two distinct endogenous opioid systems in the lateral division. Marchant NJ, Densmore VS, Osborne PB. J Comp Neurol; 2007 Oct 20; 504(6):702-15. PubMed ID: 17722034 [Abstract] [Full Text] [Related]
3. Dissecting the Roles of GABA and Neuropeptides from Rat Central Amygdala CRF Neurons in Anxiety and Fear Learning. Pomrenze MB, Giovanetti SM, Maiya R, Gordon AG, Kreeger LJ, Messing RO. Cell Rep; 2019 Oct 01; 29(1):13-21.e4. PubMed ID: 31577943 [Abstract] [Full Text] [Related]
4. GABA and NMDA receptors in CRF neurons have opposing effects in fear acquisition and anxiety in central amygdala vs. bed nucleus of the stria terminalis. Gafford GM, Ressler KJ. Horm Behav; 2015 Nov 01; 76():136-42. PubMed ID: 25888455 [Abstract] [Full Text] [Related]
5. A Corticotropin Releasing Factor Network in the Extended Amygdala for Anxiety. Pomrenze MB, Tovar-Diaz J, Blasio A, Maiya R, Giovanetti SM, Lei K, Morikawa H, Hopf FW, Messing RO. J Neurosci; 2019 Feb 06; 39(6):1030-1043. PubMed ID: 30530860 [Abstract] [Full Text] [Related]
6. Activation of corticotropin releasing factor-containing neurons in the rat central amygdala and bed nucleus of the stria terminalis following exposure to two different anxiogenic stressors. Butler RK, Oliver EM, Sharko AC, Parilla-Carrero J, Kaigler KF, Fadel JR, Wilson MA. Behav Brain Res; 2016 May 01; 304():92-101. PubMed ID: 26821289 [Abstract] [Full Text] [Related]
8. A 6-hydroxydopamine lesion of the mesostriatal dopamine system decreases the expression of corticotropin releasing hormone and neurotensin mRNAs in the amygdala and bed nucleus of the stria terminalis. Day HE, Vittoz NM, Oates MM, Badiani A, Watson SJ, Robinson TE, Akil H. Brain Res; 2002 Aug 02; 945(2):151-9. PubMed ID: 12126877 [Abstract] [Full Text] [Related]
9. Corticotropin-releasing factor gene expression is down-regulated in the central nucleus of the amygdala of alcohol-preferring rats which exhibit high anxiety: a comparison between rat lines selectively bred for high and low alcohol preference. Hwang BH, Stewart R, Zhang JK, Lumeng L, Li TK. Brain Res; 2004 Nov 05; 1026(1):143-50. PubMed ID: 15476706 [Abstract] [Full Text] [Related]
10. Desipramine and citalopram attenuate pretest swim-induced increases in prodynorphin immunoreactivity in the dorsal bed nucleus of the stria terminalis and the lateral division of the central nucleus of the amygdala in the forced swimming test. Chung S, Kim HJ, Kim HJ, Choi SH, Cho JH, Cho YH, Kim DH, Shin KH. Neuropeptides; 2014 Oct 05; 48(5):273-80. PubMed ID: 25129807 [Abstract] [Full Text] [Related]
11. Chronically elevated corticosterone in the amygdala increases corticotropin releasing factor mRNA in the dorsolateral bed nucleus of stria terminalis following duress. Shepard JD, Schulkin J, Myers DA. Behav Brain Res; 2006 Nov 01; 174(1):193-6. PubMed ID: 16934343 [Abstract] [Full Text] [Related]
17. Doxapram increases corticotropin-releasing factor immunoreactivity and mRNA expression in the rat central nucleus of the amygdala. Choi SH, Kim SJ, Park SH, Moon BH, Do E, Chun BG, Lee MS, Shin KH. Peptides; 2005 Nov 01; 26(11):2246-51. PubMed ID: 16269353 [Abstract] [Full Text] [Related]